An error was made on page 37, section GPVI receptor antagonists, in the above paper. The company currently moving Revacept® through clinical development is in fact advanceCor GmbH (Martinsried, Germany) and not ABX-CRO/ Medifacts GmbH (Goerlitz, Saxony, Germany).
. 2012 Aug 3;3:49. doi: 10.2147/JBM.S36176
Erratum
Collection date 2012.
© 2012 Yeung and Holinstat, publisher and licensee Dove Medical Press Ltd.
This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
PMCID: PMC3419511
This corrects the article "Newer agents in antiplatelet therapy: a review" on page 33.